Sinovac Biotech, Ltd.. (SVA) NASDAQ
$6.47 - (-)
Market Cap: $643.78M
As of 02/22/19 04:00 PM EST. Market open.
Sinovac Biotech, Ltd.. (SVA)
NASDAQ
$6.47
- (-)
Market Cap: $643.78M
As of 02/22/19 04:00 PM EST. Market open.
Add to Portfolio
sinovac biotech ltd. is a china-based biopharmaceutical company that focuses on research, development, manufacturing and commercialization of vaccines that protect against human infectious diseases including hepatitis a and b, seasonal influenza, h5n1 pandemic influenza (avian flu), h1n1 influenza (swine flu), and mumps, as well as animal rabies vaccine for canines. in 2009, sinovac was the first ... read more
COMPANY PROFILE
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Weidong Yin
Full Time Employees
106
URL
Address
No. 15 Zhi Tong Road,, Zhongguancun Tech Park, Changping Distr., Beijing, Beijing, 102200.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
CEO
Weidong Yin
Full Time Employees
106
URL
Address
No. 15 Zhi Tong Road,, Zhongguancun Tech Park, Changping Distr., Beijing, Beijing, 102200.
PRICE CHART FOR SINOVAC BIOTECH, LTD.
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
-
Previous Close
-
Days Range
$6.25 - $6.58
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
$643.78M
Dividend Yield
-
P/E
-
Shares Outstanding
99,502,243
Open
-
Previous Close
-
Days Range
$6.25 - $6.58
52 week range
- - -
Volume
0
Avg. Volume (30 days)
0
Market Cap
$643.78M
Dividend Yield
-
P/E
-
Shares Outstanding
99,502,243
FINANCIAL STATEMENTS FOR SINOVAC BIOTECH, LTD.
LOADING...
FUNDS WITH A POSITION IN SINOVAC BIOTECH, LTD.
Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
---|---|---|---|---|
VIVO CAPITAL, LLC | 11,800,000 | 6% | New | Other |
ORBIMED ADVISORS LLC | 2,718,735 | 6.79% | No change | Other |
BUYBACK ANNOUNCEMENT(S) FOR SINOVAC BIOTECH, LTD.
LOADING...